FDC Mutual Funds | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | FDC Ltd.

FDC Ltd. | Mutual Funds

Mutual Funds that own FDC Ltd.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

PineBridge Mauritius (GF) Ltd.

7,438,590

4.26%

64,433

1.73%

12/31/2017

Reliance Small Cap Fund

3,497,953

1.13%

08/31/2018

Fidelity Low Priced Stock Fund

3,141,164

1.8%

-108,836

0.03%

04/30/2018

UTI - Children's Career - Balanced Plan

1,770,000

1.01%

-56,673

2.46%

04/30/2018

Fidelity Northstar Fund

773,210

0.44%

0.05%

07/31/2018

UTI - Pharma & Healthcare Fund

514,967

0.3%

34,462

2.67%

08/31/2018

DFA Emerging Markets Small Cap Series

449,623

0.26%

0.02%

01/31/2018

DFA Emerging Markets Core Equity Portfolio

433,488

0.25%

2,465

0.01%

04/30/2018

PineBridge Global Funds - Asia (ex-Japan) Small Cap Equity Fd.

412,621

0.24%

0.41%

12/31/2017

254,247

0.15%

2.15%

12/31/2017

About FDC

View Profile

Address	142-48, S. V. Road Mumbai Maharashtra 400102 India
Employees	-
Website	http://www.fdcindia.com
Updated	09/14/2018
FDC Ltd. engages in the business of pharmaceutical. It presence in therapeutic segments, such as, anti-infectives, gastrointestinals, ophthalmologicals, vitamins, minerals, dietary supplements, cardiac, anti-diabetes, respiratory, gynaecology, dermatology, analgesics and others. The company products are sold under brand names, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.